Isoegomaketone alleviates inflammatory response and oxidative stress in sepsis lung injury

Allergol Immunopathol (Madr). 2024 Mar 1;52(2):16-22. doi: 10.15586/aei.v52i2.1030. eCollection 2024.

Abstract

Background: Sepsis is a life-threatening condition characterized by acute organ dysfunction, which frequently leads to acute lung injury (ALI) in approximately 40% of cases. Isoegomaketone (IK) is a constituent of essential oil found in P. frutescens, known for its diverse biological properties, including anti-inflammatory and antitumor effects. However, the regulatory impact of IK on ALI in the context of sepsis remains poorly understood.

Methods: Pathological alterations in lung tissues were assessed using hematoxylin and eosin staining. Enumeration of total leukocytes and neutrophils in bronchoalveolar lavage fluid (BALF) was performed using a hematocytometer, while the levels of interleukin (IL)-6, IL-1β, IL-10, and IL-17 in BALF were quantified using enzyme-linked immunosorbent serological assay. In addition, the levels of malondialdehyde (MDA), myeloperoxidase (MPO), superoxide dismutase (SOD), and glutathione (GSH) in lung tissues were assessed using respective commercial kits; cell apoptosis was evaluated using the terminal deoxynucleotide transferase--mediated dUTP nick end-labeling assay, and protein expressions were determined through Western blot analysis.

Results: Our findings revealed that cecal ligation and puncture (CLP) treatment in mice induced severe lung injury, characterized by increased lung injury scores, significant bleeding, neutrophil infiltration, and alveolar edema. However, treatment with IK at a dose of 10 mg/kg ameliorated CLP-induced lung injury, while IK dose of 5 mg/kg showed no significant effect. Additionally, IK treatment at 10 mg/kg reduced CLP-induced inflammation by decreasing levels of IL-6, IL-1β, IL-10, and IL-17. Furthermore, IK at 10 mg/kg attenuated CLP-induced oxidative stress by modulating levels of MDA, MPO, SOD, and GSH. Moreover, IK treatment with a dose of 10 mg/kg activated the nuclear factor erythroid 2-related factor 2-heme oxygenase-1 (Nrf2-HO-1) pathway by enhancing the protein expressions of Nrf2 and HO-1.

Conclusion: This study demonstrates that IK could mitigate the inflammatory response and oxidative stress associated with sepsis-induced ALI, supporting IK as a promising therapeutic agent for the treatment of sepsis-associated ALI.

Keywords: Inflammatory Response; Isoegomaketone; Lung Injury; Oxidative Stress.

MeSH terms

  • Acute Lung Injury* / drug therapy
  • Acute Lung Injury* / metabolism
  • Animals
  • Furans*
  • Interleukin-10 / metabolism
  • Interleukin-17 / metabolism
  • Interleukin-6 / metabolism
  • Ketones*
  • Lung / pathology
  • Mice
  • NF-E2-Related Factor 2 / metabolism
  • NF-E2-Related Factor 2 / pharmacology
  • NF-E2-Related Factor 2 / therapeutic use
  • Oxidative Stress
  • Sepsis* / complications
  • Sepsis* / drug therapy
  • Superoxide Dismutase / metabolism
  • Superoxide Dismutase / pharmacology
  • Superoxide Dismutase / therapeutic use

Substances

  • Interleukin-10
  • isoegomaketone
  • Interleukin-17
  • NF-E2-Related Factor 2
  • Interleukin-6
  • Superoxide Dismutase
  • Furans
  • Ketones